Stockscreener 앱 받기
2.8645
5.89%
-0.2701
전일 마감가:
$3.1346
열려 있는:
$3.15
하루 거래량:
469.01K
Relative Volume:
1.84
시가총액:
$1.64M
수익:
-
순이익/손실:
$-5.00M
주가수익비율:
-2.4909
EPS:
-1.15
순현금흐름:
$-3.85M
1주 성능:
-3.39%
1개월 성능:
-45.64%
6개월 성능:
-66.55%
1년 성능:
-83.54%
1일 변동 폭
$2.35
$3.17
1주일 범위
$2.35
$3.5686
52주 변동 폭
$2.35
$26.18
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
명칭
Protagenic Therapeutics Inc
전화
(212) 994-8200
주소
149 FIFTH AVENUE, NEW YORK
PTIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
2.9481 | 1.64M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.01 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.22 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.86 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.48 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.64 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Protagenic Therapeutics Inc 주식(PTIX)의 최신 뉴스
Protagenic Therapeutics Inc (PTIX) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com
Protagenic Therapeutics Announces Reverse Stock Split - TipRanks
Protagenic Therapeutics announces 1-for-14 reverse stock split - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Protagenic Takes Bold Step: 1-for-14 Reverse Split Aims to Preserve Nasdaq Listing - Stock Titan
Stock Surge: Protagenic Therapeutics Inc (PTIX) Closes at 0.23, Marking a -9.20 Increase/Decrease - DWinneX
Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.28, a 0.69 Surge/Decline - DWinneX
PTIX stock touches 52-week low at $0.25 amid sharp annual decline - MSN
Protagenic Therapeutics stockholders approve reverse split authority - Investing.com Australia
Protagenic Therapeutics stockholders approve reverse split authority By Investing.com - Investing.com South Africa
What Did We Note About Insider Trading At Protagenic Therapeutics Inc (NASDAQ: PTIX)? - stocksregister.com
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Protagenic Therapeutics, Inc.\new SEC 10-K Report - TradingView
PTIX stock plunges to 52-week low, hitting $0.23 - Investing.com India
PTIX stock plunges to 52-week low, hitting $0.23 By Investing.com - Investing.com Australia
Protagenic Therapeutics (NASDAQ:PTIX) Stock Price Down 6.5% – Here’s Why - Defense World
BDSX Shrinks Loss With Revenue Growth, ALLR Plans $5Mln Share Buyback, What's The Buzz At PTIX? - RTTNews
PTIX stock plunges to 52-week low, hitting $0.25 By Investing.com - Investing.com Canada
Protagenic Therapeutics adjusts stock option prices By Investing.com - Investing.com South Africa
Protagenic Therapeutics adjusts stock option prices - Investing.com India
Protagenic Therapeutics Reprices Stock Options at Annual Meeting - TipRanks
Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th - ACCESS Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
PTIX’s Market Whiplash: -23.55% YTD Decline, -25.97% Plunge in 30 Days - The InvestChronicle
Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.37, a 11.82 Surge/Decline - The Dwinnex
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Protagenic Therapeutics Inc (PTIX) Shares Plummet Below 1-Year High - The News Heater
Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Sees Significant Decrease in Short Interest - Defense World
Protagenic Therapeutics Announces Date of Annual Shareholder Meeting - ACCESS Newswire
Performance Tech Stock Hits 52-Week Low at $0.44 Amid Market Challenges - Investing.com
Protagenic Therapeutics, Inc. Enters into Amendment No. 1 to At Market Issuance Sales Agreement - Defense World
Protagenic Therapeutics Inc’s (PTIX) -12.44% Retreat Justifies A Second Look - Stocks Register
PTIX stock touches 52-week low at $0.45 amid market challenges - Investing.com Nigeria
Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews
Protagenic Therapeutics (NASDAQ:PTIX) Faces Delisting Threat from NasdaqUnited States Securities and Exchange CommissionWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934D - Defense World
Protagenic Therapeutics faces Nasdaq delisting over equity deficit - Investing.com
PTIX stock touches 52-week low at $0.48 amid market challenges - Investing.com India
Galapagos NV (GLPG) Stock Surges Amid Strong Industry Performanc - GuruFocus.com
Protagenic Therapeutics Receives Delist Determination Letter from Nasdaq - Defense World
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com India
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
ARMISTICE CAPITAL, LLC Acquires New Stake in Protagenic Therapeu - GuruFocus.com
Protagenic Therapeutics Inc. Warrant (PTIXW) Quarterly 10-Q Report - Quartz
Protagenic Therapeutics Inc. (PTIX) Quarterly 10-Q Report - Quartzy
Protagenic Therapeutics Completes Private Placement, Raises $1.275 Million - Defense World
Protagenic Therapeutics Inc (PTIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.52%
자본화:
|
볼륨(24시간):